Status: affected by both circulating vaccine-derived poliovirus type 2 (cVDPV2) and type 3 (cVDPV3)
Polio this week in Israel
- No cVDPV2 cases were reported this week. There has been one cVDPV2 case reported this year.
- In 2022, one cVDPV3 case was reported, with onset of paralysis on 12 February 2022, linked to cVDPV3-positive environmental samples previously detected in the country (25 positive samples in total were reported in 2022, the most recent sample was collected on 15 March 2022).
International Health Regulations
Countries affected by poliovirus circulation are subject to temporary recommendations issued by the Emergency Committee of the International Health Regulations on Poliovirus, under the auspices of the Public Health Emergency of International Concern. The latest report by the Committee is as of May 2023.
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.